The scientist’s investigation covers issues in Positron emission tomography, Nuclear medicine, Pathology, Internal medicine and Radiology. The study incorporates disciplines such as Hypoxia, Molecular imaging, Magnetic resonance imaging, Tomography and Radiation therapy in addition to Positron emission tomography. His Nuclear medicine research includes elements of Differential diagnosis, Biopsy, Carcinoma and Medical imaging.
His studies deal with areas such as Inflammation, Microglia and Multiple sclerosis as well as Pathology. His Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology, Oncology, Cortex and Cardiology. His biological study spans a wide range of topics, including MEDLINE and Spondylodiscitis.
Rudi Dierckx mostly deals with Nuclear medicine, Internal medicine, Positron emission tomography, Pathology and Radiology. His research in Nuclear medicine is mostly focused on Scintigraphy. Rudi Dierckx combines subjects such as Endocrinology, Oncology and Cardiology with his study of Internal medicine.
His study connects Magnetic resonance imaging and Positron emission tomography. The Pathology study combines topics in areas such as Inflammation and Biodistribution. Rudi Dierckx frequently studies issues relating to Pharmacology and Receptor.
His primary areas of investigation include Positron emission tomography, Nuclear medicine, Radiology, Internal medicine and Magnetic resonance imaging. The subject of his Positron emission tomography research is within the realm of Neuroscience. His Neuroscience research integrates issues from Cerebral blood flow and 5-HT receptor.
His Nuclear medicine research integrates issues from University medical, Cerebral flow and Pittsburgh compound B. His Radiology research is multidisciplinary, incorporating elements of Neuroradiology, Retrospective cohort study and Post-transplant lymphoproliferative disorder. Within one scientific family, he focuses on topics pertaining to Endocrinology under Internal medicine, and may sometimes address concerns connected to Neuroinflammation.
His main research concerns Positron emission tomography, Nuclear medicine, Radiology, Magnetic resonance imaging and Receptor. His Positron emission tomography study incorporates themes from Meta-analysis, Cancer research and Annexin A5. Rudi Dierckx works on Nuclear medicine which deals in particular with Binding potential.
The study incorporates disciplines such as Hematopoietic stem cell transplantation, Orthopedic surgery, Retrospective cohort study, Complication and Post-transplant lymphoproliferative disorder in addition to Radiology. His Magnetic resonance imaging study integrates concerns from other disciplines, such as Neuroradiology, Single-photon emission computed tomography, Perfusion scanning, Fluorodeoxyglucose and Distribution. The Receptor study which covers Pharmacology that intersects with Adenosine A2A receptor, Transplant rejection, Adenosine receptor, Immune checkpoint and Blood–brain barrier.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group.
Hani T. S. Benamer;Jim Patterson;Donald G. Grosset;J. Booij.
Movement Disorders (2000)
Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study
Janine Doorduin;Erik F. J. de Vries;Antoon T. M. Willemsen;Jan Cees de Groot.
The Journal of Nuclear Medicine (2009)
Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation
Bruno Lima Giacobbo;Janine Doorduin;Hans C Klein;Rudi A J O Dierckx.
Molecular Neurobiology (2019)
Apoptosis-detecting radioligands: current state of the art and future perspectives.
Christophe M. M. Lahorte;Jean-Luc Vanderheyden;Neil Steinmetz;Christophe Van de Wiele.
European Journal of Nuclear Medicine and Molecular Imaging (2004)
Technetium-99m RP527, a GRP analogue for visualisation of GRP receptor-expressing malignancies: a feasibility study
Christophe Van de Wiele;Filip Dumont;Rudi Vanden Broecke;Wim Oosterlinck.
European Journal of Nuclear Medicine and Molecular Imaging (2000)
Performance Characteristics of the Digital Biograph Vision PET/CT System
Joyce J van Sluis;Johan R. de Jong;Jenny Schaar;Walter Noordzij.
The Journal of Nuclear Medicine (2019)
Promising role of 18-F-fluoro-D-deoxyglucose positron emission tomography in clinical infectious diseases.
F De Winter;Dirk Vogelaers;F Gemmel;Rudi Dierckx.
European Journal of Clinical Microbiology & Infectious Diseases (2002)
PET visualization of microglia in multiple sclerosis patients using [11C]PK11195.
JC Debruyne;J Versijpt;KJ Van Laere;F De Vos.
European Journal of Neurology (2003)
Value of 11C-methionine PET in imaging brain tumours and metastases.
Andor W. J. M. Glaudemans;Roelien H. Enting;Mart A. A. M. Heesters;Rudi A. J. O. Dierckx;Rudi A. J. O. Dierckx.
European Journal of Nuclear Medicine and Molecular Imaging (2013)
The Use of F-18-FDG-PET/CT for Diagnosis and Treatment Monitoring of Inflammatory and Infectious Diseases
Andor W. J. M. Glaudemans;Erik F. J. de Vries;Filippo Galli;Rudi A. J. O. Dierckx.
Clinical & Developmental Immunology (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: